Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model

Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, José Eduardo, Puga, Renato, Lenz, Guido, Trindade, Cristiano, Filippi-Chiela, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654215/
https://www.ncbi.nlm.nih.gov/pubmed/33204396
http://dx.doi.org/10.1155/2020/5432651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654215/
https://www.ncbi.nlm.nih.gov/pubmed/33204396
http://dx.doi.org/10.1155/2020/5432651

Ejemplares similares